查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518349

动物疫苗市场：依类型、动物、给药途径、通路划分 -2030年全球预测

Veterinary Vaccines Market by Type (Live, Inactive, Recombinant) Animal (Livestock, Companion ) Administration Route (Oral, Parenteral, Nasal) Distribution Channel (Hospital & Clinic, Pharmacy) - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 250 Pages | 商品交期: 5-7个工作天内

价格

到2030年，动物疫苗市场预计将达到 111.3 亿美元，2023年至2030年年复合成长率为 6.1%。本报告基于彻底的二级和一级研究以及对市场情景的详细分析，讨论了关键的行业驱动因素、限制因素、挑战、机会、趋势等。

该市场的成长是由牲畜数量的增加、宠物拥有量的增加、动物疾病流行率的增加以及对动物性食品的需求的增加所推动的。此外，人们对动物健康的认识不断提高，动物健康和宠物保险支出的增加预计将为该市场的利益相关者创造成长机会。然而，高昂的製造和疫苗储存成本限制了该市场的成长。新兴国家对动物健康的认知不足是市场成长的主要挑战。

目录

第1章 简介

第2章 研究方法

第3章 执行摘要

第4章 市场洞察

  • 市场概览
  • 促进因素
    • 牲畜数量增加
    • 宠物数量增加
    • 人畜共通传染病和动物疾病的盛行率不断上升
    • 对动物性食品的需求不断增加
  • 抑制因素
    • 疫苗生产和储存成本高昂
  • 机会
    • 提高动物健康意识
    • 增加动物健康和宠物保险支出
  • 作业
    • 新兴国家对动物健康的认知较低
  • 趋势
  • 价格分析
  • 监理分析
  • 波特五力分析
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争程度

第5章 动物疫苗市场：依类型

  • 简介
  • 灭活​​疫苗
  • 非活性疫苗
  • 重组疫苗
  • 其他疫苗

第6章 动物疫苗市场评估：依动物类型

  • 简介
  • 牲畜
    • 反刍动物
    • 家禽
    • 猪
    • 其他牲畜
  • 伴侣动物
    • 狗
    • 猫
    • 其他伴侣动物

第7章 动物疫苗市场：依给药途径

  • 简介
  • 注射用
  • 口头
  • 鼻音

第8章 动物疫苗市场：依通路划分

  • 简介
  • 动物医院/诊所
  • 药房
  • 流动动物医院

第9章 动物疫苗市场：依地区

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东、非洲

第10章 竞争分析

  • 摘要
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 领先企业
    • 新兴公司
  • 市占率分析

第11章 公司简介（公司概况、财务概况、产品组合、策略发展）

  • Zoetis Inc.
  • Virbac
  • Ceva Sante Animale
  • Boehringer Ingelheim International
  • Phibro Animal Health Corporation
  • Merck & Co., Inc
  • Elanco Animal Health Inc.
  • Vetoquinol
  • Neogen Corporation
  • Indian Immunologicals Ltd.

（註：预计提供前 5 名公司的 SWOT 分析）

第12章 附录

Product Code: MRHC - 104935

Veterinary Vaccines Market Size, Share, Forecast, & Trends Analysis by Type (Live, Inactive, Recombinant), Animal (Livestock [Ruminant, Poultry, Pig), Companion (Dog, Cat), Administration Route (Oral, Parenteral, Nasal), End User - Global Forecast to 2030

The veterinary vaccines market is projected to reach $11.13 billion by 2030, at a CAGR of 6.1% from 2023-2030. Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends.

The growth of this market is driven by the increasing livestock population, growing pet adoption, increasing prevalence of diseases in animals, and growing demand for animal-derived food products. Additionally, increasing awareness regarding animal health and growing expenditure on animal health and pet insurance are expected to create growth opportunities for the stakeholders in this market. However, the high cost of manufacturing and vaccine storage restrain the growth of this market. Low awareness regarding animal health in developing countries is a major challenge to market growth.

Based on type, the veterinary vaccines market is segmented into live attenuated vaccines, inactive vaccines, recombinant vaccines, and other vaccines. In 2023, the live attenuated vaccines segment is expected to account for the largest share of the market. This large share can be attributed to the high effectiveness of live attenuated vaccines. Live attenuated vaccines are the most traditional type of vaccines used. When introduced into the body, these vaccines initiate an immune response against pathogens, helping the immune system fight the infection in the future.

Based on animal type, the veterinary vaccines market is segmented into livestock and companion animals. The livestock segment is expected to grow at a higher CAGR during the forecast period. Factors contributing to the segment's growth are increasing demand and consumption of animal-derived food products in developing countries, increasing livestock population to meet the growing demand, and government initiatives to prevent and reduce animal disease occurrence. The governments of several countries are undertaking various initiatives to prevent animal diseases. For instance, in 2023, the Government of India launched two initiatives, Animal Pandemic Preparedness Initiatives and World Bank-funded Animal Health System Support for One Health. These initiatives aim to strengthen integrated disease surveillance & monitoring, early warning & response, vaccine/ diagnostics, R&D, and production for animal diseases in the country.

Based on administration route, the veterinary vaccines market is segmented into parenteral, oral, and intranasal. In 2023, the parenteral segment is expected to account for the largest share of the market. The segment's large share is attributed to the animals' especially pets' reluctance towards oral vaccines and easy and high vaccine absorption through the intramuscular route. Muscle tissues have a generous blood supply; therefore, the vaccines administered are readily absorbed into the bloodstream.

Based on distribution channel, the veterinary vaccines market is segmented into veterinary hospitals & clinics, pharmacies, and mobile veterinary units. The veterinary hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The high preference for veterinary hospitals & clinics by farmers and pet owners, the growing prevalence of diseases in animals, and easy accessibility are the factors driving the growth of this segment.

An in-depth analysis of the geographical scenario of the veterinary vaccines market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to dominate the veterinary vaccines market, followed by Europe and Asia-Pacific. Well-established agriculture and animal husbandry, awareness of animal health among farmers and pet owners, high production and export of animal-derived food products, and a large pet population base are expected to support North America's largest share.

Key companies operating in the veterinary vaccines market are Zoetis Inc. (U.S.), Virbac (France), Ceva Sante Animale (France), Boehringer Ingelheim International GmbH (Germany), Phibro Animal Health Corporation (U.S.), Merck & Co., Inc (U.S.), Elanco Animal Health Inc. (U.S.), Vetoquinol (France), Neogen Corporation (U.S.), and Indian Immunologicals Ltd. (India).

Scope of the Report:

Veterinary Vaccines Market Assessment, by Type

  • Live Attenuated Vaccines
  • Inactive Vaccines
  • Recombinant Vaccines
  • Other Vaccines

(Other vaccines include Gene deleted, virus vector, subunit, DNA Plasmid, and Toxoid)

Veterinary Vaccines Market Assessment, by Animal Type

  • Livestock
    • Ruminants
    • Poultry
    • Porcine
    • Other Livestock

(Other livestock include zoo animals, horses, and camels)

  • Companion Animals
    • Canine
    • Feline
    • Other Companion Animals

(Other companion animals segment covers rabbits, guinea pigs, fish, and other small animals)

Veterinary Vaccines Market Assessment, by Administration Route

  • Parenteral
  • Oral
  • Intranasal

Veterinary Vaccines Market Assessment, by Distribution Channel

  • Veterinary Hospitals & Clinics
  • Pharmacies
  • Mobile Veterinary Units

Veterinary Vaccines Market Assessment, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Livestock Population
    • 4.2.2. Increasing Pet Population
    • 4.2.3. Rising Prevalence of Zoonotic and Animal Diseases
    • 4.2.4. Rising Demand for Animal-derived Food Products
  • 4.3. Restraints
    • 4.3.1. High Cost of Vaccine Manufacturing and Storage
  • 4.4. Opportunity
    • 4.4.1. Increasing Awareness Regarding Animal Health
    • 4.4.2. Growing Expenditure on Animal Health and Pet Insurance
  • 4.5. Challenges
    • 4.5.1. Low Awareness Regarding Animal Health in Developing Countries
  • 4.6. Trends
  • 4.7. Pricing Analysis
  • 4.8. Regulatory Analysis
  • 4.9. Porters Five Force Analysis
    • 4.9.1. Bargaining Power of Buyers
    • 4.9.2. Bargaining Power of Suppliers
    • 4.9.3. Threat of Substitute
    • 4.9.4. Threat of New Entrant
    • 4.9.5. Degree of Competition

5. Veterinary Vaccines Market-by Type

  • 5.1. Introduction
  • 5.2. Live Attenuated Vaccines
  • 5.3. Inactive Vaccines
  • 5.4. Recombinant Vaccines
  • 5.5. Other Vaccines

6. Veterinary Vaccines Market Assessment -by Animal Type

  • 6.1. Introduction
  • 6.2. Livestock
    • 6.2.1. Ruminants
    • 6.2.2. Poultry
    • 6.2.3. Porcine
    • 6.2.4. Other Livestock
  • 6.3. Companion Animals
    • 6.3.1. Canine
    • 6.3.2. Feline
    • 6.3.3. Other Companion Animals

7. Veterinary Vaccines Market-by Administration Route

  • 7.1. Introduction
  • 7.2. Parenteral
  • 7.3. Oral
  • 7.4. Intranasal

8. Veterinary Vaccines Market-by Distribution Channel

  • 8.1. Introduction
  • 8.2. Veterinary Hospitals & Clinics
  • 8.3. Pharmacies
  • 8.4. Mobile Veterinary Units

9. Veterinary Vaccines Market-by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1 Overview
  • 10.2 Key Growth Strategies
  • 10.3 Competitive Benchmarking
  • 10.4 Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 11.1. Zoetis Inc.
  • 11.2. Virbac
  • 11.3. Ceva Sante Animale
  • 11.4. Boehringer Ingelheim International
  • 11.5. Phibro Animal Health Corporation
  • 11.6. Merck & Co., Inc
  • 11.7. Elanco Animal Health Inc.
  • 11.8. Vetoquinol
  • 11.9. Neogen Corporation
  • 11.10. Indian Immunologicals Ltd.

(Note: SWOT Analysis of Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

LIST OF TABLES

  • Table 1 Global Veterinary Vaccines Market Drivers: Impact Analysis (2022-2030)
  • Table 2 Global Veterinary Vaccines Market Restraints: Impact Analysis (2022-2030)
  • Table 3 Global Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 4 Global Veterinary Live Attenuated Vaccines, by Country/Region, 2021-2030 (USD Million)
  • Table 5 Global Veterinary Inactive Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 6 Global Veterinary Recombinant Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Other Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 9 Global Livestock Animals Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 10 Global Veterinary Vaccines Market for Livestock, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Ruminant Vaccines, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Poultry Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Porcine Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Other Livestock Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Companion Animals Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 16 Global Companion Animals Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Canine Vaccines, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Feline Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Other Companion Animal Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 21 Global Parenteral Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global Oral Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Intranasal Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 25 Global Veterinary Vaccines for Veterinary Hospitals & Clinics, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global Veterinary Vaccines Market for Pharmacies, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Global Veterinary Vaccines Market for Mobile Veterinary Units, by Country/Region, 2021-2030 (USD Million)
  • Table 28 North America: Veterinary Vaccines Market, by Country, 2021-2030 (USD Million)
  • Table 29 North America: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 30 North America: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 31 North America: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 32 North America: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 33 North America: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 34 North America: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 35 U.S.: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 36 U.S.: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 37 U.S.: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 38 U.S.: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 39 U.S.: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 40 U.S.: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 41 Canada: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 42 Canada: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 43 Canada: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 44 Canada: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 45 Canada: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 46 Canada: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 47 Europe: Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 48 Europe: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 49 Europe: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 50 Europe: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 51 Europe: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 52 Europe: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 53 Europe: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 54 Germany: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 55 Germany: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 56 Germany: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 57 Germany: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 58 Germany: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 59 Germany: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 60 France: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 61 France: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 62 France: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 63 France: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 64 France: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 65 France: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 66 U.K.: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 67 U.K.: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 68 U.K.: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 69 U.K.: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 70 U.K.: Veterinary Vaccines Market, by Administration Route, 2021-2030 (USD Million)
  • Table 71 U.K.: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 72 Italy: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 73 Italy: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 74 Italy: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 75 Italy: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 76 Italy: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 77 Italy: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 78 Spain: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 79 Spain: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 80 Spain: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 81 Spain: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 82 Spain: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 83 Spain: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 84 RoE: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 85 RoE: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 86 RoE: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 87 RoE: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 88 RoE: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 89 RoE: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 90 Asia-Pacific: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 91 Asia-Pacific: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 92 Asia-Pacific: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 93 Asia-Pacific: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 94 Asia-Pacific: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 95 Asia-Pacific: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 96 Japan: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 97 Japan: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 98 Japan: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 99 Japan: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 100 Japan: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 101 Japan: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 102 China: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 103 China: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 104 China: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 105 China: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 106 China: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 107 China: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 108 India: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 109 India: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 110 India: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 111 India: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 112 India: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 113 India: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 114 RoAPAC: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 115 RoAPAC: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 116 RoAPAC: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 117 RoAPAC: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 118 RoAPAC: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 119 RoAPAC: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 120 Latin America: Veterinary Vaccines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 121 Latin America: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 122 Latin America: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 123 Latin America: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 124 Latin America: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 125 Latin America: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 126 Latin America: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 127 Brazil: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 128 Brazil: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 129 Brazil: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 130 Brazil: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 131 Brazil: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 132 Brazil: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 133 Mexico: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 134 Mexico: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 135 Mexico: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 136 Mexico: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 137 Mexico: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 138 Mexico: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 139 Rest of Latin America: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 140 Rest of Latin America: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 141 Rest of Latin America: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 142 Rest of Latin America: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 143 Rest of Latin America: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 144 Rest of Latin America: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 145 Middle East & Africa: Veterinary Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 146 Middle East & Africa: Veterinary Vaccines Market, by Animal Type, 2021-2030 (USD Million)
  • Table 147 Middle East & Africa: Livestock Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 148 Middle East & Africa: Companion Animal Vaccines Market, by Type, 2021-2030 (USD Million)
  • Table 149 Middle East & Africa: Veterinary Vaccines Market, by Administration Rute, 2021-2030 (USD Million)
  • Table 150 Middle East & Africa: Veterinary Vaccines Market, by Distribution Channel, 2021-2030 (USD Million)
  • Table 151 Recent Developments, by Company (2020-2024)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Veterinary Vaccines Market, by Type, 2024 Vs. 2030 (USD Million)
  • Figure 8 Global Veterinary Vaccines Market, by Animal Type, 2024 Vs. 2030 (USD Million)
  • Figure 9 Global Veterinary Vaccines Market, by Administration Route, 2024 Vs. 2030 (USD Million)
  • Figure 10 Global Veterinary Vaccines Market, by Distribution Channel, 2024 Vs. 2030 (USD Million)
  • Figure 11 Global Veterinary Vaccines Market, by Geography
  • Figure 12 Market Dynamics: Veterinary Vaccines Market
  • Figure 13 Global Veterinary Vaccines Market, by Type, 2024 Vs. 2030 (USD Million)
  • Figure 14 Global Veterinary Vaccines Market, by Animal Type, 2024 Vs. 2030 (USD Million)
  • Figure 15 Global Veterinary Vaccines Market, by Administration Route, 2024 Vs. 2030 (USD Million)
  • Figure 16 Global Veterinary Vaccines Market, by Distribution Channel, 2024 Vs. 2030 (USD Million)
  • Figure 17 Global Veterinary Vaccines Market, by Geography, 2024 Vs. 2030 (USD Million)
  • Figure 18 North America: Veterinary Vaccines Market Snapshot
  • Figure 19 Europe: Veterinary Vaccines Market Snapshot
  • Figure 20 Asia-Pacific: Veterinary Vaccines Market Snapshot
  • Figure 21 Latin America: Veterinary Vaccines Market Snapshot
  • Figure 22 Key Growth Strategies Adopted by Leading Players (2020-2022)
  • Figure 23 Global Veterinary Vaccines Market: Competitive Benchmarking Based on Type
  • Figure 24 Global Veterinary Vaccines Market: Competitive Benchmarking Based on Geography
  • Figure 25 Market Share Analysis: Veterinary Vaccines Market (2022)
  • Figure 26 Zoetis Inc.: Financial Overview (2022)
  • Figure 27 Virbac: Financial Overview (2022)
  • Figure 28 Boehringer Ingelheim International GmbH: Financial Overview (2022)
  • Figure 29 Phibro Animal Health Corporation: Financial Overview (2022)
  • Figure 30 Merck & Co., Inc: Financial Overview (2022)
  • Figure 31 Elanco Animal Health Inc.: Financial Overview (2022)
  • Figure 32 Neogen Corporation: Financial Overview (2022)